Surmodics Total Assets 2010-2025 | SRDX

Surmodics total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Surmodics Annual Total Assets
(Millions of US $)
2024 $179
2023 $186
2022 $158
2021 $195
2020 $169
2019 $160
2018 $164
2017 $137
2016 $133
2015 $99
2014 $105
2013 $102
2012 $104
2011 $157
2010 $170
2009 $186
Surmodics Quarterly Total Assets
(Millions of US $)
2025-03-31 $163
2024-12-31 $164
2024-09-30 $179
2024-06-30 $177
2024-03-31 $183
2023-12-31 $180
2023-09-30 $186
2023-06-30 $189
2023-03-31 $166
2022-12-31 $170
2022-09-30 $158
2022-06-30 $176
2022-03-31 $184
2021-12-31 $185
2021-09-30 $195
2021-06-30 $177
2021-03-31 $177
2020-12-31 $164
2020-09-30 $169
2020-06-30 $166
2020-03-31 $156
2019-12-31 $155
2019-09-30 $160
2019-06-30 $150
2019-03-31 $151
2018-12-31 $151
2018-09-30 $164
2018-06-30 $160
2018-03-31 $163
2017-12-31 $135
2017-09-30 $137
2017-06-30 $132
2017-03-31 $131
2016-12-31 $129
2016-09-30 $133
2016-06-30 $127
2016-03-31 $122
2015-12-31 $112
2015-09-30 $99
2015-06-30 $96
2015-03-31 $91
2014-12-31 $87
2014-09-30 $105
2014-06-30 $101
2014-03-31 $96
2013-12-31 $95
2013-09-30 $102
2013-06-30 $104
2013-03-31 $108
2012-12-31 $108
2012-09-30 $104
2012-06-30 $158
2012-03-31 $154
2011-12-31 $152
2011-09-30 $157
2011-06-30 $173
2011-03-31 $172
2010-12-31 $172
2010-09-30 $170
2010-06-30 $191
2010-03-31 $191
2009-12-31 $191
2009-09-30 $186
2009-06-30 $182
2009-03-31 $182
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.415B $0.126B
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.146B 27.67
Boston Scientific (BSX) United States $150.504B 37.68
Stryker (SYK) United States $142.511B 29.80
EssilorLuxottica (ESLOY) France $130.598B 0.00
Medtronic (MDT) Ireland $110.517B 15.67
Lonza Group Ag (LZAGY) Switzerland $49.287B 0.00
Haleon (HLN) United Kingdom $47.240B 26.92
ResMed (RMD) United States $36.670B 27.54
Agilent Technologies (A) United States $32.977B 21.50
GE HealthCare Technologies (GEHC) United States $32.574B 15.47
Terumo (TRUMY) Japan $26.206B 34.04
Insulet (PODD) United States $21.421B 84.09
Koninklijke Philips (PHG) Netherlands $20.782B 14.94
Zimmer Biomet Holdings (ZBH) United States $17.848B 11.46
Baxter (BAX) United States $15.354B 11.46
Smith & Nephew SNATS (SNN) United Kingdom $12.539B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $9.087B 0.00
Bio-Rad Laboratories (BIO) United States $6.271B 21.82
Lantheus Holdings (LNTH) United States $5.391B 13.60
Prestige Consumer Healthcare (PBH) United States $4.135B 18.47
Perrigo (PRGO) Ireland $3.612B 9.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.315B 15.10
ICU Medical (ICUI) United States $3.199B 23.59
Envista Holdings (NVST) United States $3.124B 25.96
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.830B 40.91
AtriCure (ATRC) United States $1.614B 0.00
Acuren (TIC) United States $1.361B 0.00
AdaptHealth (AHCO) United States $1.148B 11.66
Neogen (NEOG) United States $1.146B 14.67
Green Thumb Industries (GTBIF) United States $1.048B 23.57
BioLife Solutions (BLFS) United States $1.033B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.845B 8.52
Kestra Medical Technologies (KMTS) United States $0.774B 0.00
CeriBell (CBLL) United States $0.641B 0.00
Evolus (EOLS) United States $0.596B 0.00
Owens & Minor (OMI) United States $0.583B 4.83
Capricor Therapeutics (CAPR) United States $0.557B 0.00
Curaleaf Holdings (CURLF) Canada $0.549B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.532B 0.00
Valneva SE (VALN) France $0.500B 0.00
Tilray Brands (TLRY) Canada $0.387B 0.00
SNDL (SNDL) Canada $0.336B 0.00
Aurora Cannabis (ACB) Canada $0.331B 58.80
VAREX IMAGING (VREX) United States $0.320B 11.77
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Viemed Healthcare (VMD) United States $0.261B 22.00
Sanuwave Health (SNWV) United States $0.256B 0.00
Cerus (CERS) United States $0.250B 0.00
Sanara MedTech (SMTI) United States $0.247B 0.00
ZimVie (ZIMV) United States $0.244B 11.08
Canopy Growth (CGC) Canada $0.243B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Cresco Labs (CRLBF) United States $0.233B 0.00
Biote (BTMD) United States $0.215B 6.05
OraSure Technologies (OSUR) United States $0.210B 0.00
Brainsway (BWAY) Israel $0.208B 54.95
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Omeros (OMER) United States $0.188B 0.00
Organigram Global (OGI) Canada $0.184B 0.00
High Tide (HITI) Canada $0.182B 0.00
Verano Holdings (VRNOF) United States $0.181B 0.00
Utah Medical Products (UTMD) United States $0.175B 14.28
Exagen (XGN) United States $0.165B 0.00
Vireo Growth (VREOF) United States $0.136B 0.00
FitLife Brands (FTLF) United States $0.128B 15.72
Jin Medical (ZJYL) China $0.108B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.087B 11.26
MacroGenics (MGNX) United States $0.086B 0.00
Veru (VERU) United States $0.085B 0.00
TerrAscend (TSNDF) Canada $0.082B 0.00
Quipt Home Medical (QIPT) United States $0.080B 0.00
Agape ATP (ATPC) $0.076B 0.00
Cytosorbents (CTSO) United States $0.075B 0.00
Zynex (ZYXI) United States $0.071B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.043B 0.00
Nephros (NEPH) United States $0.040B 54.00
United-Guardian (UG) United States $0.038B 12.97
Rockwell Medical (RMTI) United States $0.031B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00